Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ecohealth ; 15(4): 864-870, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-30117000

RESUMO

At the end of 2016, Brazil experienced an unprecedented yellow fever (YF) outbreak. Clinical, molecular and ecological aspects of human and non-human primate (NHP) samples collected at the beginning of the outbreak are described in this study. Spatial distribution analyses demonstrated a strong overlap between human and NHP cases. Through molecular analyses, we showed that the outbreak had a sylvatic origin, caused by the South American genotype 1 YFV, which has already been shown to circulate in Brazil. As expected, the clusters of cases were identified in regions with a low vaccination coverage. Our findings highlight the importance of the synchronization of animal surveillance and health services to identify emerging YF cases, thereby promoting a better response to the vulnerable population.


Assuntos
Febre Amarela/epidemiologia , Vírus da Febre Amarela/genética , Vírus da Febre Amarela/isolamento & purificação , Aedes/virologia , Animais , Brasil/epidemiologia , Doenças Transmissíveis Emergentes , Surtos de Doenças , Humanos , Primatas/microbiologia
2.
Science ; 361(6405): 894-899, 2018 08 31.
Artigo em Inglês | MEDLINE | ID: mdl-30139911

RESUMO

The yellow fever virus (YFV) epidemic in Brazil is the largest in decades. The recent discovery of YFV in Brazilian Aedes species mosquitos highlights a need to monitor the risk of reestablishment of urban YFV transmission in the Americas. We use a suite of epidemiological, spatial, and genomic approaches to characterize YFV transmission. We show that the age and sex distribution of human cases is characteristic of sylvatic transmission. Analysis of YFV cases combined with genomes generated locally reveals an early phase of sylvatic YFV transmission and spatial expansion toward previously YFV-free areas, followed by a rise in viral spillover to humans in late 2016. Our results establish a framework for monitoring YFV transmission in real time that will contribute to a global strategy to eliminate future YFV epidemics.


Assuntos
Surtos de Doenças/prevenção & controle , Monitoramento Epidemiológico , Genômica/métodos , Febre Amarela/prevenção & controle , Febre Amarela/transmissão , Vírus da Febre Amarela/isolamento & purificação , Aedes/virologia , Fatores Etários , Animais , Brasil/epidemiologia , Surtos de Doenças/estatística & dados numéricos , Evolução Molecular , Humanos , Filogenia , Reação em Cadeia da Polimerase , Risco , Fatores Sexuais , Análise Espaço-Temporal , Febre Amarela/epidemiologia , Febre Amarela/virologia , Vírus da Febre Amarela/classificação , Vírus da Febre Amarela/genética
3.
Food Chem Toxicol ; 59: 405-11, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23793037

RESUMO

Roots of Galianthe thalictroides K. Schum. (Rubiaceae) are used in folk medicine in the State of Mato Grosso do Sul, Brazil, for treating and preventing cancer. To gain information about the genotoxicity of extracts (aqueous and EtOH), the CHCl3 phase resulting from partition of the EtOH extract and the indole monoterpene alkaloid 1 obtained from this plant. The genotoxicity of 1 and extracts was evaluated in vivo through the Drosophila melanogaster wing Somatic Mutation and Recombination Test - SMART, while in vitro cytotoxic (MTT) and Comet assays were performed only with alkaloid 1. The results obtained with the SMART test indicated that the aqueous extract had no genotoxic activity. The EtOH extract was not genotoxic to ST descendants but genotoxic to HB ones. The CHCl3 phase was genotoxic and cytotoxic. Alkaloid 1 showed significant mutational events with SMART, in the cytotoxicity assay (MTT), it showed a high cytotoxicity for human hepatoma cells (HepG2), whereas for the Comet assay, not showing genotoxic activity. The ethanol extract was shown to be genotoxic to HB descendants in the SMART assay, while the results obtained in this test for the monoterpene indole alkaloid 1 isolated from this extract.


Assuntos
Antineoplásicos Fitogênicos/efeitos adversos , Hepatócitos/efeitos dos fármacos , Alcaloides Indólicos/efeitos adversos , Monoterpenos/efeitos adversos , Extratos Vegetais/efeitos adversos , Rubiaceae/química , Animais , Antineoplásicos Fitogênicos/química , Antineoplásicos Fitogênicos/isolamento & purificação , Antineoplásicos Fitogênicos/farmacologia , Brasil , Carcinoma Hepatocelular/tratamento farmacológico , Sobrevivência Celular/efeitos dos fármacos , Ensaio Cometa , Etnofarmacologia , Células Hep G2 , Humanos , Alcaloides Indólicos/química , Alcaloides Indólicos/isolamento & purificação , Alcaloides Indólicos/farmacologia , Neoplasias Hepáticas/tratamento farmacológico , Estrutura Molecular , Monoterpenos/química , Monoterpenos/isolamento & purificação , Monoterpenos/farmacologia , Testes de Mutagenicidade , Extratos Vegetais/química , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/farmacologia , Raízes de Plantas/química , Solubilidade , Solventes/química , Temperatura , Moduladores de Tubulina/efeitos adversos , Moduladores de Tubulina/química , Moduladores de Tubulina/isolamento & purificação , Moduladores de Tubulina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...